Instil Bio, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €10.34K
    Gross profit
    -€10.34K
    SG&A expenses
    €31.30M
    R&D expenses
    €20.00M
    EBITDA
    -€68.10M
    D&A
    €1.43M
    EBIT
    -€67.99M
    Interest expenses
    €3.88M
    EBT
    -€72.81M
    Tax expenses
    -€818.23K
    Net income
    -€72.81M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €41.72M
    Changes in working capital
    -€4.92M
    Operating cash flow
    -€37.32M
    Capex
    €0.00
    Other investing cash flow
    -€9.15M
    Net investing cash flow
    €33.29M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €348.07K
    Debt repayment
    €2.38M
    Other financing cash flow
    €3.57M
    Net financing cash flow
    €6.29M
    Foreign exchange effects
    €128.37K
    Net change in cash
    €5.81M
    Cash at end of period
    €6.75M
    Free cash flow
    -€37.32M

    Balance sheet

    Cash and cash equivalents
    €6.62M
    Cash and short-term investments
    €79.11M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €99.56M
    Total current assets
    €178.67M
    Property, plant & equipment
    €637.55K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €10.04M
    Other non-current assets
    €9.65M
    Total non-current assets
    €20.33M
    Total assets
    €199.01M
    Accounts payable
    €450.59K
    Short-term debt
    €0.00
    Other current liabilities
    €11.48M
    Total current liabilities
    €11.93M
    Long-term debt
    €5.17K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €73.63M
    Total non-current liabilities
    €73.63M
    Total liabilities
    €85.57M
    Common stock
    €0.00
    Retained earnings
    -€607.14M
    Other equity
    -€693.55K
    Total equity
    €113.44M
    Total liabilities and shareholders' equity
    €199.01M

    Company information

    Market capitalization
    €128.52M
    Employees
    14
    Enterprise Value
    €239.83M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -64.2% Much better than peer group: -101.8%
    ROA
    -36.6% Better than peer group: -53.2%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -29.0%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€5.20M

    Notifications